2022
DOI: 10.1097/md.0000000000030806
|View full text |Cite
|
Sign up to set email alerts
|

BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report

Abstract: Rationale: The relationship between rheumatoid arthritis (RA) and eosinophilic inflammation is unclear. According to recent studies, it has been suggested that T helper 2 cell responses play a role in the inhibition of RA. It is unclear how the immunological response after coronavirus disease-2019 (COVID-19) vaccination affects T cell immune reactions. Patient concerns and diagnoses: Here, we report the case of an 88-year-old woman diagnosed with RA and chronic eosinophilic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Rheumatoid arthritis (RA) is an inflammatory autoimmune disease characterized by the presence of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) that cause inflammation [ 86 ]. Seven cases of de novo RA following COVID-19 vaccination have been reported, with a higher incidence in women (4/7, 57%) [ 14 , [87] , [88] , [89] , [90] , [91] ]. Four of these were reported after the mRNA vaccine and one after the Viral vector vaccine.…”
Section: Resultsmentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is an inflammatory autoimmune disease characterized by the presence of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) that cause inflammation [ 86 ]. Seven cases of de novo RA following COVID-19 vaccination have been reported, with a higher incidence in women (4/7, 57%) [ 14 , [87] , [88] , [89] , [90] , [91] ]. Four of these were reported after the mRNA vaccine and one after the Viral vector vaccine.…”
Section: Resultsmentioning
confidence: 99%